To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.
118-HR-4490118th CongressIntroduced Jul 6, 2023Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the Subcommittee on Health.
Sponsor
Rep. Guthrie, Brett [R-KY-2](R-KY-2)4 cosponsors
Summary
This bill broadens the authority of pharmacies under the Controlled Substances Act to deliver certain controlled substances to health care practitioners for the purpose of administering the substance to a patient.
Under current law, pharmacies may deliver controlled substances in schedules III, IV, or V to a practitioner if it is for maintenance or detoxification treatment and is administered via injection or implantation, among other requirements. The bill applies this authority to any controlled substance in schedules III, IV, or V that is approved by the Food and Drug Administration to be administered by, or under the supervision of, a practitioner.
Subjects
Drug trafficking and controlled substancesHealth personnelPrescription drugs
Actions (5)
Referred to the Subcommittee on Health.
Jul 7, 2023House committee actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 6, 2023House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 6, 2023House floor actions
Introduced in House
Jul 6, 2023Library of Congress
Introduced in House
Jul 6, 2023Library of Congress